Hospital care and procedures
Page highlights
In 2023–24, there were around 143,000 coronary angiography procedures reported for patients admitted to hospital – 96,000 (67%) for males and 47,300 (33%) for females.
This section provides an overview of hospital care for all cardiovascular diseases (CVD) in the Australian population. A hospitalisation for CVD may be for medical, surgical, or other acute care, for subacute care (for example rehabilitation) or for non-acute care (for example, maintenance care for a person with limitations due to a cardiovascular condition).
Many patients who are hospitalised with acute cardiovascular events will be cared for in a specialist unit:
- in 2023–24, there were 102 coronary care units in Australian public hospitals and a further 39 cardiac surgery units (AIHW 2025)
- in 2026, there were 117 specialised stroke units (Stroke Foundation, personal communication, 10 March 2026).
Length of stay in hospital
The length of time that people spend in hospital for CVD has decreased over the past 3 decades. Among those hospitalised for one night or more with CVD as a principal diagnosis:
- the average length of stay declined from 9.6 days in 1993–94 to 7.9 days in 2007–08 and 6.2 days in 2023–24
- in 2023–24, 31% of people admitted to hospital with CVD were discharged on the same day
- patients with stroke tended to stay longest – an average of 12.3 days, followed by patients with congenital heart disease (9.1 days), peripheral arterial disease (6.6 days), and coronary heart disease (4.4 days)
- The average length of stay in hospital increased with age. Those aged 85 and over stayed an average of 7.3 days, compared with 4.7 days for those aged 25–34 years. The longer lengths of stay among older people reflect the increased complexity and multiplicity of their conditions.
Hospital procedures
This section reports on a range of common procedures which diagnose or treat CVD and are performed on patients admitted to hospital.
Coronary angiography: a diagnostic procedure which provides a picture of the coronary arteries – those that supply blood to the heart itself – to determine whether they may be narrowed or blocked. A catheter is guided to the heart where a special dye is released into the coronary arteries before X-rays are taken. Coronary angiography provides medical professionals with the information to decide on treatment options, such as the need for coronary revascularisation procedures.
Echocardiography: a diagnostic procedure which takes moving pictures of the heart using high frequency sound waves (ultrasound).
With these it is possible to measure the size of the various heart chambers, to study the appearance and motions of the heart valves, and to assess blood flow through the heart.
Imaging services, including intraoperative ultrasounds are not usually coded on hospital records, although transoesophageal echocardiogram (TOE) are an exception and are generally coded. Note, however, that the numbers reported here may be underestimates.
Percutaneous coronary interventions (PCI): restore blood flow to blocked coronary arteries. There are 2 types: coronary angioplasty without stent, and coronary stenting.
Coronary angioplasty involves inserting a catheter with a small balloon into a coronary artery, which is inflated to clear the blockage. Coronary stenting is similar, but involves inserting a stent (an expandable mesh tube) into the affected coronary arteries.
Coronary artery bypass grafting: Coronary artery bypass grafting (CABG) is a surgical procedure that uses blood vessel grafts to bypass blockages in the coronary arteries and restore adequate blood flow to the heart muscle. The surgery involves taking a blood vessel from a patient’s inner chest, arm or leg and attaching it to the vessels on the outside of the heart to bypass a blocked artery.
Heart valve repair or replacement: procedures that are performed when the normal flow of blood through the heart is disrupted by damaged valves, making it harder for the heart to pump blood effectively. This can lead to heart failure. The damage to heart valves may be caused by acute rheumatic fever or rheumatic heart disease, coronary heart disease, or forms of congenital heart disease.
Pacemaker insertion: Pacemakers are small devices that are placed in the chest or abdomen to help control abnormal heart rhythms. These devices use electrical pulses to prompt the heart to beat at a normal rate.
Cardiac defibrillator implant: A cardiac defibrillator implant is a device implanted into a patient’s chest that monitors the heart rhythm and delivers electric shocks to the heart when required to eliminate abnormal rhythms. They are effective in preventing sudden cardiac death in people at high risk of the life-threatening cardiac arrhythmia known as ventricular fibrillation.
Carotid endarterectomy: Carotid endarterectomy is a procedure where atherosclerotic plaques are surgically removed from the carotid arteries in the neck, which supply blood to the brain. This procedure is used to reduce the risk of stroke caused by blockage.
Heart transplants: A heart transplant involves implanting a working heart from a recently deceased organ donor into a patient. It is generally used to treat severe forms of heart failure or coronary artery disease.
Coronary angiography
In 2023–24, there were around 143,000 coronary angiography procedures reported for patients admitted to hospital – 96,000 (67%) for males and 47,300 (33%) for females.
Between 2000–01 and 2023–24, the age-standardised rate of coronary angiography procedures in males increased by 4.9% and 0.7% in females.
Echocardiography
In 2023–24, there were around 58,400 echocardiography procedures reported for patients admitted to hospital – 39,500 (68%) for males and 18,900 (32%) for females.
The age-standardised rate of echocardiography procedures reported for males was 2.2 times as high as for females.
Percutaneous coronary interventions
In 2023–24, around 46,400 PCIs were performed on patients admitted to hospital – 34,600 (75%) for males and 11,700 (25%) for females.
Between 2000–01 and 2023–24, the age-standardised rate of PCIs increased 23% among males and 14% among females (Figure 1).
Coronary artery bypass grafting
In 2023–24, there were around 12,600 CABG procedures performed on patients admitted to hospital – 10,500 (84%) for males and 2,100 (16%) for females.
Between 2000–01 and 2023–24, the age-standardised rate of CABG decreased by 54% in males, and 70% in females. This reflects changes in technology and clinical practice, as well as improved primary and secondary prevention (Figure 1).
Although rates of CABG have declined, the procedure remains a recommended treatment for certain patients with complex cardiovascular conditions (NHFA & CSANZ 2016).
Heart valve repair or replacement
In 2023–24, there were around 14,700 heart valve repair or replacement procedures performed on patients admitted to hospital – 9,400 (64%) for males and 5,300 (36%) for females.
The age-standardised rate of heart valve repair or replacement procedures was 2 times higher among males than females.
Pacemaker insertion
In 2023–24, there were around 21,700 pacemaker insertion procedures performed on patients admitted to hospital – 13,300 (61%) for males and 8,500 (39%) for females.
The age-standardised rate of pacemaker insertion procedures was 1.9 times as high among males as females.
Cardiac defibrillator implant
In 2023–24, there were around 4,100 cardiac defibrillator implant procedures performed on patients admitted to hospital – 3,200 (77%) for males and 923 (23%) for females.
The age-standardised rate of cardiac defibrillator implant procedures was 20 per 100,000 population in males, and 5.6 per 100,000 population in females.
Carotid endarterectomy
In 2023–24, there were around 1,800 carotid endarterectomy procedures performed on patients admitted to hospital – 1,400 (74%) for males and 470 (26%) for females.
The age-standardised rate of carotid endarterectomy procedures was 3.2 times higher among males compared with females.
Heart transplants
In 2023–24, there were 121 heart transplants performed – 97 (80%) for males and 24 (20%) for females.
The age-standardised rate of heart transplants was 3.9 times as high among males compared with females.
The Australian and New Zealand Organ Donation Registry (ANZOD) records and reports on organ donation within Australia and New Zealand. Of the 527 deceased organ donors in 2024 in Australia, 114 (22%) had a heart retrieved. From these heart donors there were 105 heart transplant recipients. Of these, 5 received heart/double lung transplants and 2 received a combined heart/kidney transplant (ANZOD 2025).
Figure 1: Percutaneous coronary interventions and coronary artery bypass grafts, by sex, 2000–01 to 2023–24
Line chart shows rates of coronary artery bypass grafts have decreased over time, whereas rates of percutaneous coronary interventions have remained relatively stable.
| Year | Males | Females | Persons |
|---|---|---|---|
| 2000–01 | 177.9 | 57.4 | 115.8 |
| 2001–02 | 186.6 | 60.5 | 121.5 |
| 2002–03 | 212.2 | 68.0 | 137.6 |
| 2003–04 | 235.0 | 75.2 | 152.3 |
| 2004–05 | 246.3 | 78.9 | 159.8 |
| 2005–06 | 252.4 | 79.4 | 162.9 |
| 2006–07 | 247.7 | 78.6 | 160.4 |
| 2007–08 | 239.4 | 73.6 | 153.6 |
| 2008–09 | 238.2 | 72.4 | 152.4 |
| 2009–10 | 236.6 | 72.9 | 152.1 |
| 2010–11 | 240.6 | 74.8 | 154.9 |
| 2011–12 | 235.8 | 71.1 | 150.7 |
| 2012–13 | 230.8 | 68.8 | 147.1 |
| 2013–14 | 227.8 | 66.2 | 144.3 |
| 2014–15 | 236.3 | 68.0 | 149.2 |
| 2015–16 | 237.0 | 70.0 | 150.5 |
| 2016–17 | 241.6 | 72.6 | 154.1 |
| 2017–18 | 244.2 | 73.1 | 155.6 |
| 2018–19 | 247.0 | 71.1 | 155.7 |
| 2019–20 | 237.7 | 69.8 | 150.6 |
| 2020–21 | 243.1 | 71.7 | 154.2 |
| 2021–22 | 216.6 | 64.0 | 137.5 |
| 2022–23 | 220.3 | 66.0 | 140.1 |
| 2023–24 | 218.6 | 65.5 | 139.0 |
| Year | Males | Females | Persons |
|---|---|---|---|
| 2000–01 | 140.5 | 39.2 | 87.7 |
| 2001–02 | 133.4 | 37.6 | 83.5 |
| 2002–03 | 128.5 | 35.4 | 80.0 |
| 2003–04 | 122.9 | 33.0 | 76.0 |
| 2004–05 | 112.5 | 30.8 | 69.9 |
| 2005–06 | 108.5 | 29.0 | 67.1 |
| 2006–07 | 106.2 | 27.7 | 65.3 |
| 2007–08 | 99.8 | 25.4 | 61.1 |
| 2008–09 | 95.4 | 24.9 | 58.8 |
| 2009–10 | 86.0 | 21.8 | 52.7 |
| 2010–11 | 83.7 | 21.1 | 51.2 |
| 2011–12 | 81.5 | 19.3 | 49.2 |
| 2012–13 | 79.6 | 18.7 | 48.0 |
| 2013–14 | 83.2 | 18.3 | 49.6 |
| 2014–15 | 80.2 | 17.4 | 47.7 |
| 2015–16 | 78.9 | 16.6 | 46.7 |
| 2016–17 | 76.2 | 15.5 | 44.8 |
| 2017–18 | 72.2 | 15.2 | 42.7 |
| 2018–19 | 72.3 | 14.0 | 42.2 |
| 2019–20 | 70.8 | 13.6 | 41.2 |
| 2020–21 | 69.3 | 13.2 | 40.3 |
| 2021–22 | 68.4 | 12.5 | 39.5 |
| 2022–23 | 68.3 | 13.0 | 39.7 |
| 2023–24 | 64.9 | 11.9 | 37.4 |
Notes
1. Age-standardised to the 2001 Australian Standard Population.
2. Includes persons with missing information on age and/or sex.
3. Hospital procedures are for admitted patients only.
Source:
AIHW National Hospital Morbidity Database.
AIHW (Australian Institute of Health and Welfare) (2025) Hospitals. Admitted patients, Hospital resources 2022–23 tables, Table 5.6, AIHW, Australian Government, accessed 23 February 2026.
ANZOD (Australia and New Zealand Organ Donation Registry) (2025) ANZOD Annual Report 2025, ANZOD, Adelaide, accessed 22 January 2026.
NHFA (National Heart Foundation of Australia) & CSANZ (Cardiac Society of Australia and New Zealand) (2016) ‘Australian clinical guidelines for the management of acute coronary syndromes 2016’, Heart, Lung and Circulation, 25:895–951, doi:10.1016/j.hlc.2016.06.789.